TL;DR
Herpes Simplex Virus 1 (HSV-1) hijacks neuronal cells for replication and latency, with the viral protein ICP0 playing a key role. This study uses advanced proteomic techniques to identify novel cellular targets of ICP0 in neurons, revealing that ICP0 manipulates host proteins SNX9 and OTUD4 to promote viral infection and suppress antiviral responses.
What Problem Does This Paper Address?
Herpes Simplex Virus 1 (HSV-1) is a neurotropic virus that can cause both acute infections and establish lifelong latency in neurons. A critical viral protein, ICP0, acts as an E3 ubiquitin ligase and is essential for initiating productive infection and reactivating from latency. While ICP0's importance is established, its specific cellular targets within neurons, which are the primary site of HSV-1 latency and reactivation, have not been systematically identified. Understanding these targets is crucial for deciphering how HSV-1 manipulates host cells to establish infection and evade immune defenses. This paper aims to fill this knowledge gap by comprehensively identifying and functionally characterizing ICP0's targets in neuronal cells.
Methods
The researchers employed a two-pronged proteomic approach:
- Interactome Analysis: This involved identifying proteins that physically bind to ICP0. They used mass spectrometry (specifically, liquid chromatography-mass spectrometry/mass spectrometry or LC-MS/MS) after co-immunoprecipitation (Co-IP) to pull down ICP0 and its interacting partners from infected neuronal (Neuro-2a) and non-neuronal (293T, HFF) cells.
- Ubiquitinome Analysis: This technique identifies proteins that are ubiquitinated by ICP0. They used a method involving immunoprecipitation of ubiquitin remnants from digested cellular proteins, followed by TMT labeling and LC-MS/MS. This allowed them to pinpoint potential ICP0 substrates by looking for increased ubiquitination in the presence of ICP0.
These proteomic findings were then validated through:
- Co-immunoprecipitation (Co-IP): To confirm direct physical interactions between ICP0 and candidate proteins.
- Overexpression and Knockdown Experiments: Using plasmids to increase protein levels and siRNAs to decrease them, to assess the functional impact of candidate proteins on viral replication and host antiviral responses.
- Quantitative Reverse-Transcription PCR (qRT-PCR): To measure changes in mRNA levels of specific genes.
- Luciferase Assays: To quantify the activity of the IFN-β promoter, a key indicator of type I interferon response.
Datasets
The study utilized established cell lines:
- Vero cells: A standard cell line for viral studies.
- 293T cells: Human embryonic kidney cells, commonly used in molecular biology.
- Neuro-2a cells: Mouse neuroblastoma cells, chosen to represent neuronal cells.
- HFF cells: Human foreskin fibroblast cells.
- Primary mouse TG neurons: Neurons isolated from mouse trigeminal ganglia, providing a more direct model of neuronal infection.
The study also used well-characterized HSV-1 strains: KOS (wild-type), 7134 (ICP0-null mutant), and 7134R (ICP0-rescued derivative).
Key Insights and Ideas
- ICP0's broad reach in neurons: The study confirms ICP0's critical role in neuronal infection and reveals a surprisingly diverse set of cellular proteins it interacts with and modifies.
- SNX9 as a viral restriction factor: The identification of SNX9 as an ICP0 interactor and its ability to restrict the replication of the ICP0-null virus suggests it acts as a cellular defense mechanism that ICP0 must overcome.
- OTUD4 as a key player in antiviral response: The finding that OTUD4 is upregulated during infection and enhances type I interferon production highlights its role in the innate immune defense against HSV-1.
- ICP0's antagonistic role: Crucially, the study demonstrates that ICP0 can antagonize the antiviral functions of both SNX9 and OTUD4, effectively dampening the host's immune response and promoting viral replication. This suggests a sophisticated mechanism by which ICP0 manipulates host cellular machinery.
- Crosstalk between ubiquitination and SUMOylation: For VIM, the study observed overlap between identified ubiquitination sites and previously known SUMOylation sites, hinting at complex post-translational modification crosstalk.
Key Results
- The study identified 37 potential ICP0-interacting proteins in Neuro-2a cells, with 26 being neuron-specific.
- Co-immunoprecipitation assays validated interactions between ICP0 and several proteins, including ACOT8, C1QBP, OTUD4, SNX9, and VIM.
- Knockdown of SNX9 significantly increased the replication of the ICP0-null virus (7134) in Neuro-2a cells, indicating SNX9's restrictive role.
- Ubiquitinome analysis identified 351 potential ICP0 ubiquitination substrates.
- OTUD4 and VIM were confirmed as novel substrates of ICP0-mediated ubiquitination in Neuro-2a cells.
- OTUD4 expression was upregulated during HSV-1 infection, independently of ICP0's E3 ligase activity.
- Overexpression of OTUD4 enhanced type I interferon (IFN-α and IFN-β) expression during infection with the ICP0-null virus but not with wild-type virus, suggesting ICP0 interferes with OTUD4's antiviral function.
Limitations and Future Work
- Mouse vs. Human Cell Differences: While Neuro-2a cells are a good model for neuronal cells, the authors acknowledge that results from mouse cells might miss interactions occurring in human cells. They addressed this by including 293T and HFF cells in their analysis.
- Transient Interactions: The authors note that some interactions might be too transient to be detected by immunoprecipitation, as suggested by PML being identified in the ubiquitinome but not the interactome.
- Functional Studies Scope: While SNX9 and OTUD4 were functionally validated, the study identified many other potential targets that warrant further investigation.
- In Vivo Relevance: The study primarily uses cell culture models. Future work could focus on validating these findings in animal models to understand their in vivo relevance for HSV-1 pathogenesis and latency.
- Mechanism of SNX9 Restriction: The precise mechanism by which SNX9 restricts HSV-1 replication remains to be elucidated.
- OTUD4's Antiviral Pathway: While OTUD4's role in enhancing type I interferon production is shown, the specific pathway it targets (e.g., MAVS) needs further detailed investigation in the context of HSV-1 infection.
- VIM's Role: The role of VIM in HSV-1 infection, particularly its potential involvement in inflammation, requires further exploration, possibly in animal models.
Summary updated